Stock comparison
UnitedHealth
UNH$347.35BHealthcare Market cap, Sector
United Therapeutics
UTHR$24.02BHealthcare Market cap, Sector
Overall winner
United Therapeutics
UNH 07 UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
UNH0wins
7winsUTHR
44F
B71
67C
B76
29F
B76
23F
C62
37F
D46
36F
C64
39F
C64
Side-by-side metrics
| Metric | UNH | UTHR |
|---|---|---|
| Market cap | Winner: $347.35B | $24.02B |
| P/E (TTM) | 29.0x | 19.2x Winner |
| EV/EBIT | 21.0x | 15.2x Winner |
| ROIC (TTM) | 8.09% | 18.81% Winner |
| Gross margin | 18.8% | 86.58% Winner |
| Net margin | 2.68% | 40.61% Winner |
| Revenue CAGR 5y | 11.69% | 17.22% Winner |
| EPS CAGR 5y | -7.83% | 29.84% Winner |
| Debt / Equity | 0.7x | - Winner |
| Dividend yield | Winner: 2.3% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UNH leads on
- Dividend yield2.3%vs 0.0%+100%
- Market cap$347.35Bvs $24.02B+93%
UTHR leads on
- EPS CAGR 5y29.84%vs -7.83%+126%
- Debt / Equity-vs 0.7x+100%
- Net margin40.61%vs 2.68%+93%
- Gross margin86.58%vs 18.8%+78%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.